近40年来,全世界儿童1型糖尿病(T1DM)发病率每年递增3%~5%[1]。人类为了阻止T1DM的发生与发展,前所未有的规模与速度实施基础与临床的试验研究已取得突破性成就。免疫疗法的崛起给T1DM防治带来了光明。适时应用免疫治疗可避免T1DM易感人群发病。然而,习惯于只有胰岛素治疗1型糖尿病的传统概念使病人及其家 In the past 40 years, the incidence of type 1 diabetes (T1DM) in children worldwide has been increasing by 3% to 5% annually [1]. In order to prevent the occurrence and development of T1DM, humans have made breakthrough achievements in basic and clinical experimental researches on an unprecedented scale and speed. The rise of immunotherapy has brought bright light to T1DM prevention and treatment. Timely application of immunotherapy to prevent the incidence of T1DM susceptible population. However, the traditional concept accustomed to insulin-only type 1 diabetes makes patients and their homes